- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-3-3-mer
- Ligands
- 9 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 21 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 4 residues within 4Å:- Chain A: Q.95, S.109, N.111, K.122
No protein-ligand interaction detected (PLIP)NAG-NAG.3: 6 residues within 4Å:- Chain A: E.133, I.135, M.143, N.148
- Chain C: V.115
- Chain G: D.73
No protein-ligand interaction detected (PLIP)NAG-NAG.6: 4 residues within 4Å:- Chain A: N.246, N.277, S.279, I.353
No protein-ligand interaction detected (PLIP)NAG-NAG.7: 7 residues within 4Å:- Chain A: N.59, T.187, N.227
- Chain G: A.106
- Chain J: Y.31, Y.33, F.92
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:T.187
- Hydrogen bonds: A:N.59
NAG-NAG.8: 4 residues within 4Å:- Chain A: D.282, N.285, S.346, N.348
No protein-ligand interaction detected (PLIP)NAG-NAG.9: 5 residues within 4Å:- Chain A: D.220, I.221, N.240, W.289, T.292
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:T.292
NAG-NAG.10: 5 residues within 4Å:- Chain A: T.316, T.317, N.330, Q.357
- Ligands: NAG.41
No protein-ligand interaction detected (PLIP)NAG-NAG.14: 4 residues within 4Å:- Chain B: Q.95, S.109, N.111, K.122
No protein-ligand interaction detected (PLIP)NAG-NAG.15: 6 residues within 4Å:- Chain A: V.115
- Chain B: E.133, I.135, M.143, N.148
- Chain H: D.73
No protein-ligand interaction detected (PLIP)NAG-NAG.18: 5 residues within 4Å:- Chain B: N.246, N.277, S.279, I.353, S.386
No protein-ligand interaction detected (PLIP)NAG-NAG.19: 8 residues within 4Å:- Chain B: N.59, T.187, E.226, N.227
- Chain H: A.106
- Chain K: Y.31, Y.33, F.92
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:T.187
NAG-NAG.20: 4 residues within 4Å:- Chain B: D.282, N.285, S.346, N.348
No protein-ligand interaction detected (PLIP)NAG-NAG.21: 4 residues within 4Å:- Chain B: D.220, I.221, N.240, W.289
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:W.289
NAG-NAG.22: 6 residues within 4Å:- Chain B: T.316, T.317, N.330, S.332, Q.357
- Ligands: NAG.48
No protein-ligand interaction detected (PLIP)NAG-NAG.26: 4 residues within 4Å:- Chain C: Q.95, S.109, N.111, K.122
No protein-ligand interaction detected (PLIP)NAG-NAG.27: 6 residues within 4Å:- Chain B: V.115
- Chain C: E.133, I.135, M.143, N.148
- Chain I: D.73
No protein-ligand interaction detected (PLIP)NAG-NAG.30: 4 residues within 4Å:- Chain C: N.246, N.277, S.279, I.353
No protein-ligand interaction detected (PLIP)NAG-NAG.31: 8 residues within 4Å:- Chain C: N.59, T.187, E.226, N.227
- Chain I: A.106
- Chain L: Y.31, Y.33, F.92
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:T.187
NAG-NAG.32: 3 residues within 4Å:- Chain C: D.282, N.285, N.348
No protein-ligand interaction detected (PLIP)NAG-NAG.33: 6 residues within 4Å:- Chain C: D.220, I.221, N.240, Q.288, W.289, T.292
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:Q.288, C:T.292
NAG-NAG.34: 6 residues within 4Å:- Chain C: T.316, T.317, N.330, S.332, Q.357
- Ligands: NAG.55
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.5: 13 residues within 4Å:- Chain A: T.160, E.162, V.205, L.212, N.213, F.320, T.321, G.323, I.379, S.386, S.387
- Chain H: Q.1
- Ligands: NAG.42
3 PLIP interactions:2 interactions with chain A, 1 interactions with chain H- Hydrogen bonds: A:G.323, A:S.386, H:Q.1
NAG-NAG-BMA-MAN-MAN.17: 12 residues within 4Å:- Chain B: T.160, E.162, V.205, L.212, N.213, F.320, T.321, G.323, S.386, S.387
- Chain I: Q.1
- Ligands: NAG.50
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:G.323, B:S.386
NAG-NAG-BMA-MAN-MAN.29: 11 residues within 4Å:- Chain C: T.160, E.162, L.212, N.213, F.320, T.321, G.323, S.386, S.387
- Chain G: Q.1
- Ligands: NAG.57
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:G.323, C:S.386
- 2 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.12: 19 residues within 4Å:- Chain A: N.246, T.248, R.272, H.275, N.277, I.353
- Chain M: Q.102, R.103, I.104, Y.105, G.106, V.107, V.108
- Chain P: S.23, N.43, Q.45, P.59, D.60, I.61
2 PLIP interactions:2 interactions with chain M- Hydrogen bonds: M:Y.105, M:V.108
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.36: 20 residues within 4Å:- Chain C: T.248, R.272, H.275, N.277, I.353, L.384
- Chain O: Q.102, R.103, I.104, Y.105, G.106, V.107, V.108
- Chain R: S.23, N.43, N.44, Q.45, P.59, D.60, I.61
2 PLIP interactions:2 interactions with chain O- Hydrogen bonds: O:Y.105, O:V.108
- 1 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.24: 20 residues within 4Å:- Chain B: T.248, R.272, H.275, N.277, I.353
- Chain N: Q.102, R.103, I.104, Y.105, G.106, V.107, V.108, Y.116
- Chain Q: S.23, N.43, N.44, Q.45, P.59, D.60, N.62
1 PLIP interactions:1 interactions with chain N- Hydrogen bonds: N:Y.105, N:V.108, N:Q.102
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.37: 2 residues within 4Å:- Chain A: V.52, N.53
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain A: E.50, N.192
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain A: N.252
- Chain P: N.62
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain A: N.299, H.405
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain A: G.333, N.336
- Ligands: NAG-NAG.10
Ligand excluded by PLIPNAG.42: 6 residues within 4Å:- Chain A: L.216, S.242, S.386, N.388
- Ligands: NAG-NAG-BMA-MAN-MAN.5, NAG-NAG-BMA-MAN-MAN.5
Ligand excluded by PLIPNAG.43: 5 residues within 4Å:- Chain A: D.401, N.402, S.403
- Chain J: A.2, T.4
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain B: V.52, N.53
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain B: N.192
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain B: N.252
- Chain Q: N.62
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain B: N.299, H.405
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain B: G.333, N.336
- Ligands: NAG-NAG.22
Ligand excluded by PLIPNAG.49: 1 residues within 4Å:- Chain B: N.402
Ligand excluded by PLIPNAG.50: 5 residues within 4Å:- Chain B: L.216, S.242, S.386, N.388
- Ligands: NAG-NAG-BMA-MAN-MAN.17
Ligand excluded by PLIPNAG.51: 2 residues within 4Å:- Chain C: V.52, N.53
Ligand excluded by PLIPNAG.52: 2 residues within 4Å:- Chain C: E.50, N.192
Ligand excluded by PLIPNAG.53: 2 residues within 4Å:- Chain C: N.252
- Chain R: N.62
Ligand excluded by PLIPNAG.54: 2 residues within 4Å:- Chain C: N.299, H.405
Ligand excluded by PLIPNAG.55: 3 residues within 4Å:- Chain C: G.333, N.336
- Ligands: NAG-NAG.34
Ligand excluded by PLIPNAG.56: 2 residues within 4Å:- Chain C: N.402, S.403
Ligand excluded by PLIPNAG.57: 5 residues within 4Å:- Chain C: L.216, S.242, S.386, N.388
- Ligands: NAG-NAG-BMA-MAN-MAN.29
Ligand excluded by PLIPNAG.58: 1 residues within 4Å:- Chain D: N.102
Ligand excluded by PLIPNAG.59: 1 residues within 4Å:- Chain E: N.102
Ligand excluded by PLIPNAG.60: 1 residues within 4Å:- Chain F: N.102
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dam, K.A. et al., HIV-1 CD4-binding site germline antibody-Env structures inform vaccine design. Nat Commun (2022)
- Release Date
- 2022-11-09
- Peptides
- Envelope glycoprotein gp120: ABC
Envelope glycoprotein gp41: DEF
BG24 with an inferred germline CDRL1 Fab heavy chain: GHI
BG24 with an inferred germline CDRL1 Fab light chain: JKL
10-1074 Fab heavy chain: MNO
10-1074 Fab light chain: PQR - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
LM
MN
NO
OP
PQ
QR
R
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-3-3-mer
- Ligands
- 9 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 21 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dam, K.A. et al., HIV-1 CD4-binding site germline antibody-Env structures inform vaccine design. Nat Commun (2022)
- Release Date
- 2022-11-09
- Peptides
- Envelope glycoprotein gp120: ABC
Envelope glycoprotein gp41: DEF
BG24 with an inferred germline CDRL1 Fab heavy chain: GHI
BG24 with an inferred germline CDRL1 Fab light chain: JKL
10-1074 Fab heavy chain: MNO
10-1074 Fab light chain: PQR - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
LM
MN
NO
OP
PQ
QR
R